National Institute for Occupational Safety and Health (NIOSH); World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC), 42918-42919 [2019-17690]
Download as PDF
<![CDATA[
42918
Federal Register / Vol. 84, No. 160 / Monday, August 19, 2019 / Notices
information is necessary and whether it
will have practical utility; whether our
estimate of the public burden of this
collection of information is accurate and
based on valid assumptions and
methodology; and ways to enhance the
quality, utility, and clarity of the
information to be collected.
Obtaining Copies of Proposals:
Requesters may obtain a copy of the
information collection supporting
statement from the General Services
Administration, Regulatory Secretariat
Division, 1800 F Street NW,
Washington, DC 20405.
Please cite OMB Control No. 3090–
XXXX, Construction Manager as
Constructor, in all correspondence.
Jeffrey A. Koses,
Senior Procurement Executive, Office of
Acquisition Policy, Office of Governmentwide Policy.
[FR Doc. 2019–17699 Filed 8–16–19; 8:45 am]
BILLING CODE 6820–61–P
patients or consumers of health
information technology. Nominations
should be sent to the email or mailing
address listed below. Acknowledgement
of submissions will be provided within
a week of submission.
DATES: Letters of nomination and
resumes should be submitted no later
than September 27, 2019, to ensure
adequate opportunity for review and
consideration of nominees prior to
appointment.
ADDRESSES: Submit letters of
nomination and resumes by email:
HITCommittee@gao.gov. The address for
materials sent by mail is U.S. GAO,
Attn: HIT Committee, 441 G Street NW,
Washington, DC 20548.
FOR FURTHER INFORMATION CONTACT: Will
Simerl at (404) 679–1888 or simerlw@
gao.gov if you do not receive an
acknowledgment or need additional
information. For general information,
contact GAO’s Office of Public Affairs,
(202) 512–4800.
Authority: Public Law 114–255, sec.
3002(d) (2016), 42 U.S.C. 300jj–12.
GOVERNMENT ACCOUNTABILITY
OFFICE
Gene L. Dodaro,
Comptroller General of the United States.
Request for Health Information
Technology Advisory Committee
(HITAC) Nominations
[FR Doc. 2019–17736 Filed 8–16–19; 8:45 am]
BILLING CODE 1610–02–P
Government Accountability
Office (GAO).
ACTION: Request for letters of
nomination and resumes.
AGENCY:
The 21st Century Cures Act
established HITAC to provide
recommendations to the National
Coordinator for Health Information
Technology on policies, standards,
implementation specifications, and
certification criteria relating to the
implementation of a health information
technology infrastructure that advances
the electronic access, exchange, and use
of health information. The Act gave the
Comptroller General of the United
States responsibility for appointing a
portion of HITAC’s members. The Act
requires that members at least reflect
providers, ancillary health care workers,
consumers, purchasers, health plans,
health information technology
developers, researchers, patients,
relevant Federal agencies, and
individuals with technical expertise on
health care quality, system functions,
privacy, security, and on the electronic
exchange and use of health information,
including the use standards for such
activity. GAO is now accepting
nominations for HITAC appointments
that will be effective January 1, 2020.
From these nominations, GAO expects
to appoint at least two new HITAC
members, including one advocate for
SUMMARY:
jspears on DSK3GMQ082PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
VerDate Sep<11>2014
16:29 Aug 16, 2019
Jkt 247001
Centers for Disease Control and
Prevention
National Institute for Occupational
Safety and Health (NIOSH); World
Trade Center Health Program
Scientific/Technical Advisory
Committee (WTCHP STAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC National Institute for Occupational
Safety and Health (NIOSH), announces
the following meeting for the World
Trade Center Health Program Scientific/
Technical Advisory Committee (WTCHP
STAC). This meeting is open to the
public, limited only by the number of
telephone lines. The room will
accommodate approximately 100
persons. The public is also welcome to
listen to the meeting by dial-in 1 (800)
988–0212, the passcode 1440561, and
will accommodate up to 50 callers. To
view the web conference, enter the
following web address in your web
browser: https://
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
odniosh.adobeconnect.com/
wtchpstac19-1/.
DATES: The meeting will be held on
September 18, 2019, 10:30 a.m. to 4:00
p.m., EDT.
Public Comment Time and Date:
September 18, 2019, 10:45 a.m. to 11:00
a.m., EDT.
Please note that the public comment
period ends at the time indicated above
or following the last call for comments,
whichever is earlier. Members of the
public who want to comment must sign
up by providing their name to Mia
Wallace, Committee Management
Specialist, by phone: (404) 498–2553,
email: MWallace@cdc.gov, or the
addresses provided below by September
4, 2019. Each commenter will be
provided up to five minutes for
comment. A limited number of time
slots are available and will be assigned
on a first come-first served basis.
Written comments will also be accepted
from those unable to attend the public
session.
ADDRESSES: Jacob J. Javits Federal
Building, 26 Federal Plaza, Rooms A/B,
New York, New York 10278.
FOR FURTHER INFORMATION CONTACT:
Tania Carreo´n-Valencia, Ph.D.,
Designated Federal Officer, World Trade
Center Health Program Associate
Director for Science, 1600 Clifton Rd.
NE, MS: R–12, Atlanta, GA 30329–4027;
telephone (513) 841–4515; email: wtcstac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was
established by Title I of the James
Zadroga 9/11 Health and Compensation
Act of 2010, Public Law 111–347
(January 2, 2011), amended by Public
Law 114–113 (Dec. 18, 2015), adding
Title XXXIII to the Public Health
Service Act (codified at 42 U.S.C.
300mm to 300mm–61).
Purpose: The purpose of the WTCHP
STAC is to review scientific and
medical evidence and to make
recommendations to the World Trade
Center (WTC) Program Administrator
regarding additional WTC Health
Program eligibility criteria, potential
additions to the list of covered WTCrelated health conditions, and research
regarding certain health conditions
related to the September 11, 2001
terrorist attacks.
Title XXXIII of the PHS Act
established the WTC Health Program
within the Department of Health and
Human Services (HHS). The WTC
Health Program provides medical
monitoring and treatment benefits to
eligible firefighters and related
personnel, law enforcement officers,
and rescue, recovery, and cleanup
E:\FR\FM\19AUN1.SGM
19AUN1
jspears on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 84, No. 160 / Monday, August 19, 2019 / Notices
workers who responded to the
September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in
Shanksville, Pennsylvania (responders),
and to eligible persons who were
present in the dust or dust cloud on
September 11, 2001 or who worked,
resided, or attended school, childcare,
or adult daycare in the New York City
disaster area (survivors). Certain specific
activities of the WTC Program
Administrator are reserved to the
Secretary, HHS, to delegate at his
discretion; other WTC Program
Administrator duties not explicitly
reserved to the Secretary, HHS, are
assigned to the Director, NIOSH. The
administration of the WTCHP STAC is
left to the Director of NIOSH in his role
as WTC Program Administrator. CDC
and NIOSH provide funding, staffing,
and administrative support services for
the WTCHP STAC. The charter was
reissued on May 12, 2019, and will
expire on May 12, 2021.
Policy on Redaction of Committee
Meeting Transcripts (Public Comment):
Transcripts will be prepared and posted
to https://www.regulations.gov within 60
days after the meeting. If a person
making a comment gives his or her
name, no attempt will be made to redact
that name. NIOSH will take reasonable
steps to ensure that individuals making
public comments are aware of the fact
that their comments (including their
name, if provided) will appear in a
transcript of the meeting posted on a
public website. Such reasonable steps
include a statement read at the start of
the meeting stating that transcripts will
be posted and names of speakers will
not be redacted. If, in making a
statement, individuals reveal personal
information (e.g., medical information)
about themselves, that information will
not usually be redacted. The CDC
Freedom of Information Act coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and, if deemed
appropriate, will redact such
information. Disclosures of information
concerning third party medical
information will be redacted.
Matters To Be Considered: The agenda
will include discussions on research
integration activities that the WTC
Health Program is undertaking,
including research evaluation and
strategic planning; an update on the
policies and procedures in effect within
the WTC Health Program that are used
to determine whether sufficient
evidence is available to support adding
a non-cancer condition to the List of
WTC-Related Health Conditions; and an
update on the development of the
Inventory of 9/11 Agents that the
VerDate Sep<11>2014
16:29 Aug 16, 2019
Jkt 247001
Program will use for administrative
purposes. Agenda items are subject to
change as priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2019–17690 Filed 8–16–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to the Advisory Council
for the Elimination of Tuberculosis
(ACET)
ACTION:
Notice.
The Centers for Disease
Control and Prevention (CDC) is seeking
nominations for membership on the
ACET. The ACET consists of 10 experts
in fields associated with public health,
epidemiology, immunology, infectious
disease, pulmonary disease, pediatrics,
tuberculosis, microbiology, or
preventive health care delivery. They
are selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS). ACET provides advice
and recommendations regarding
eliminating tuberculosis (TB) to the
Secretary, HHS; the Assistant Secretary
for Health, HHS; and the CDC Director.
ACET (a) makes recommendations
regarding TB prevention and control
policies, strategies, objectives, and
priorities; (b) addresses development
and application of new technologies; (c)
provides guidance and review of CDC’s
TB prevention research portfolio and
program priorities; and (d) reviews the
extent to which progress has been made
toward eliminating TB. Nominations are
being sought for individuals who have
expertise and qualifications necessary to
contribute to the accomplishments of
ACET’s objectives. Nominees will be
selected on the basis of their expertise
in public health, epidemiology,
immunology, infectious diseases,
pulmonary disease, pediatrics,
SUMMARY:
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
42919
tuberculosis, microbiology, or
preventive health care delivery. Federal
employees are ineligible for
membership. Members may be invited
to serve for up to four year terms.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of ACET’s
objectives.
DATES: Nominations for ACET
membership must be received no later
than August 31, 2019. Packages received
after that date will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to 1600 Clifton Road NE,
Mailstop E07, Atlanta, GA 30329–4027;
or emailed (recommended) to zkr7@
cdc.gov; or faxed to 404–639–8600.
FOR FURTHER INFORMATION CONTACT:
Margie Scott-Cseh, Committee
Management Specialist, NCHHSTP,
CDC, 1600 Clifton Road NE, Mailstop
E07, Atlanta, GA 30329–4027;
telephone: 404–639–8317; email: zkr7@
cdc.gov.
SUPPLEMENTARY INFORMATION: The U.S.
Department of Health and Human
Services policy stipulates that
committee membership be balanced in
terms of points of view represented, and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens,
and cannot be full-time employees of
the U.S. Government. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Committee
members are Special Government
Employees (SGEs), requiring the filing
of financial disclosure reports at the
beginning and annually during their
terms. CDC reviews potential candidates
for ACET membership each year, and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in July 2020, or as
soon as the HHS selection process is
complete. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year. SGE Nominees must be
U.S. citizens, and cannot be full-time
employees of the U.S. Government.
Candidates should submit the following
items:
E:\FR\FM\19AUN1.SGM
19AUN1
]]>Agencies
[Federal Register Volume 84, Number 160 (Monday, August 19, 2019)]
[Notices]
[Pages 42918-42919]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17690]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
National Institute for Occupational Safety and Health (NIOSH);
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
National Institute for Occupational Safety and Health (NIOSH),
announces the following meeting for the World Trade Center Health
Program Scientific/Technical Advisory Committee (WTCHP STAC). This
meeting is open to the public, limited only by the number of telephone
lines. The room will accommodate approximately 100 persons. The public
is also welcome to listen to the meeting by dial-in 1 (800) 988-0212,
the passcode 1440561, and will accommodate up to 50 callers. To view
the web conference, enter the following web address in your web
browser: https://odniosh.adobeconnect.com/wtchpstac19-1/.
DATES: The meeting will be held on September 18, 2019, 10:30 a.m. to
4:00 p.m., EDT.
Public Comment Time and Date: September 18, 2019, 10:45 a.m. to
11:00 a.m., EDT.
Please note that the public comment period ends at the time
indicated above or following the last call for comments, whichever is
earlier. Members of the public who want to comment must sign up by
providing their name to Mia Wallace, Committee Management Specialist,
by phone: (404) 498-2553, email: [email protected], or the addresses
provided below by September 4, 2019. Each commenter will be provided up
to five minutes for comment. A limited number of time slots are
available and will be assigned on a first come-first served basis.
Written comments will also be accepted from those unable to attend the
public session.
ADDRESSES: Jacob J. Javits Federal Building, 26 Federal Plaza, Rooms A/
B, New York, New York 10278.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
Designated Federal Officer, World Trade Center Health Program Associate
Director for Science, 1600 Clifton Rd. NE, MS: R-12, Atlanta, GA 30329-
4027; telephone (513) 841-4515; email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was established by Title I of the James
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347
(January 2, 2011), amended by Public Law 114-113 (Dec. 18, 2015),
adding Title XXXIII to the Public Health Service Act (codified at 42
U.S.C. 300mm to 300mm-61).
Purpose: The purpose of the WTCHP STAC is to review scientific and
medical evidence and to make recommendations to the World Trade Center
(WTC) Program Administrator regarding additional WTC Health Program
eligibility criteria, potential additions to the list of covered WTC-
related health conditions, and research regarding certain health
conditions related to the September 11, 2001 terrorist attacks.
Title XXXIII of the PHS Act established the WTC Health Program
within the Department of Health and Human Services (HHS). The WTC
Health Program provides medical monitoring and treatment benefits to
eligible firefighters and related personnel, law enforcement officers,
and rescue, recovery, and cleanup
[[Page 42919]]
workers who responded to the September 11, 2001, terrorist attacks in
New York City, at the Pentagon, and in Shanksville, Pennsylvania
(responders), and to eligible persons who were present in the dust or
dust cloud on September 11, 2001 or who worked, resided, or attended
school, childcare, or adult daycare in the New York City disaster area
(survivors). Certain specific activities of the WTC Program
Administrator are reserved to the Secretary, HHS, to delegate at his
discretion; other WTC Program Administrator duties not explicitly
reserved to the Secretary, HHS, are assigned to the Director, NIOSH.
The administration of the WTCHP STAC is left to the Director of NIOSH
in his role as WTC Program Administrator. CDC and NIOSH provide
funding, staffing, and administrative support services for the WTCHP
STAC. The charter was reissued on May 12, 2019, and will expire on May
12, 2021.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to https://www.regulations.gov within 60 days after the meeting. If a person
making a comment gives his or her name, no attempt will be made to
redact that name. NIOSH will take reasonable steps to ensure that
individuals making public comments are aware of the fact that their
comments (including their name, if provided) will appear in a
transcript of the meeting posted on a public website. Such reasonable
steps include a statement read at the start of the meeting stating that
transcripts will be posted and names of speakers will not be redacted.
If, in making a statement, individuals reveal personal information
(e.g., medical information) about themselves, that information will not
usually be redacted. The CDC Freedom of Information Act coordinator
will, however, review such revelations in accordance with the Freedom
of Information Act and, if deemed appropriate, will redact such
information. Disclosures of information concerning third party medical
information will be redacted.
Matters To Be Considered: The agenda will include discussions on
research integration activities that the WTC Health Program is
undertaking, including research evaluation and strategic planning; an
update on the policies and procedures in effect within the WTC Health
Program that are used to determine whether sufficient evidence is
available to support adding a non-cancer condition to the List of WTC-
Related Health Conditions; and an update on the development of the
Inventory of 9/11 Agents that the Program will use for administrative
purposes. Agenda items are subject to change as priorities dictate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-17690 Filed 8-16-19; 8:45 am]
BILLING CODE 4163-18-P
